This article is reprinted from National Review with the permission of the author.

The tide is really turning against the gender ideologues who advocate experimenting on the bodies of children as a supposedly “medically necessary” treatment. Now, Italy’s National Bioethics Committee has recommended substantially ending the use of puberty-blocking drugs as a “treatment” for childhood gender confusion. From the Society for Evidence Based Gender Medicine’s press release:

The November 2024 guidance states that puberty blockers should only be provided after mental health interventions failed, and only in the context of proper research trials. The CNB’s key recommendations are:

● Clinical trials should follow the double-blind, randomized, controlled model, ensuring robust data.

● Puberty blocker prescriptions for gender dysphoria should occur only after the documented failure of psychotherapy or psychiatric interventions.

● All clinical assessments must be multidisciplinary, and decisions thoroughly documented.

● Use of puberty blockers outside clinical trials for this indication must adhere to the same rigorous criteria, with all data transmitted to a national registry

Excellent. If the government follows the advice of its bioethics commission, Italy will join a burgeoning list of countries — which includes the U.K., France, New Zealand, Finland, Norway, Sweden, France, and Denmark actively taking steps to end the madness.

Once the execrable Admiral Levine is out of office as Trump reenters the presidency, I expect the U.S. to follow suit. That will leave the American medical establishment and a short list of cobalt-blue states like California among a shrinking cadre of jurisdictions and institutions still insisting that doctors provide emotionally confused children with what is ridiculously called “gender-affirming care.”